Bifera Rx™ Iron Supplement Tablets | BiferaRx

04:35 EDT 27th August 2014 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Rx Only

BiferaRx™ is a prescription iron supplement. BiferaRx™ is a small oval, film-coated maroon tablet, with black core, debossed and bisected with "AP|85" on one side, and plain on the other.

Each BiferaRx™ tablet contains:

Amount per serving
Folic Acid 1 mg
B12 (as cyanocobalamin) 25 mcg
  as PIC (polysaccharide iron complex) 22 mg
  as HIP (heme iron polypeptide as Proferrin® Proferrin® is a registered trademark of Colorado Biolabs, Inc. Cozad, NE.
BiferaRx™ is a trademark of Alaven® Pharmaceutical LLC, Marietta, GA.
- bovine source, USDA certified)
6 mg

Microcrystalline cellulose, croscarmellose sodium, crospovidone, magnesium stearate, silicon dioxide, coating (polyvinyl alcohol, polyethylene glycol, talc, FD&C red no. 40 aluminum lake, titanium dioxide, FD&C blue no. 2 aluminum lake).

BiferaRx™ is a prescription iron supplement indicated for use in improving the nutritional status of iron deficiency.

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Hemochromatosis and hemosiderosis are contraindications to iron therapy.

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6.

Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Folic acid when administered as a single agent in doses above 0.1mg daily may obscure pernicious anemia in that hematological remission can occur while neurological manifestations remain progressive. While prescribing this nutritional supplement for pregnant women, nursing mothers, or for women prior to conception, their medical condition and other drugs, herbs, and/or supplements consumption should be considered.

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

One tablet daily with or without food or as prescribed by a licensed healthcare provider with prescribing authority.

BiferaRx™ tablets are supplied in child-resistant bottles of 90 tablets (NDC 68220-085-90) and as a Professional Sample 5 tablet blister pack (NDC 68220-085-25).


Store at controlled room temperature 20°-25°C (68°-77°F). Excursions permitted to 15°-30°C (59°-86°F). [See current USP]

Dispense in a tight, light-resistant container to protect from light and moisture.

U.S. Patent No. 7,585,527

For medical inquiries call toll free 1-888-317-0001

Manufactured for: ALAVEN PHARMACEUTICAL LLCMarietta, GA 30062

6-085-00-01-0310 CL085-00-01-0210

19/03/10      6:20 PM

NDC 68220-085-9090 Tablets

Bifera Rx™Iron Supplement

Rx Only

Manufactured for: ALAVEN PHARMACEUTICAL LLCMarietta, GA 30062

IMAGE bifera-01.jpg


Alaven Pharmaceutical LLC

Active Ingredients


Drugs and Medications [0 Results]


Clinical Trials [0 Results]


PubMed Articles [0 Results]


Quick Search


Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Drugs and Medication Quicklinks

Searches Linking to this Drug Record